文献速递间质性肺疾病

肺超声评分评估结缔组织病相关间质性肺病:性能及与CT定量的比较

A Lung Ultrasound Score for Assessing Connective Tissue Disease-Related Interstitial Lung Disease: Performance and Comparison With Computed Tomography Quantification.
PubMed 文献 · Respirology · 2025-12-10

这项前瞻性研究纳入206例临床怀疑间质性肺病(ILD)的结缔组织病(CTD)患者,采用14肋间扫描方案的肺超声(LUS)评分,并与人工智能定量CT(QCT)参数、肺功能及KBILD问卷进行相关分析。结果显示LUS评分可区分非ILD、临床前ILD和ILD,且与QCT纤维化范围等参数正相关。

要点

  • LUS评分 cutoff 5.5 区分非ILD与临床前ILD,灵敏度93.1%、特异度83.9%。
  • LUS评分 cutoff 14.5 区分非ILD与ILD,灵敏度93.8%、特异度86.9%。
  • LUS评分与QCT纤维化范围正相关(r=0.784,p<0.001)。

核心结论

  • LUS有助于CTD-ILD的早期诊断,定量LUS评分与QCT定义的ILD范围相关。

研究设计与样本

  • LUS采用14肋间扫描方案,HRCT采用人工智能QCT软件分析,患者完成肺功能测试和KBILD问卷。

主要发现

  • 206例中ILD组145例、临床前ILD组30例、非ILD组31例。
  • ILD患者LUS评分和QCT参数高于非ILD或临床前ILD患者,肺功能结果和KBILD评分则较低。
  • LUS评分 cutoff 5.5 区分非ILD与临床前ILD的灵敏度93.1%、特异度83.9%。
  • LUS评分 cutoff 14.5 区分非ILD与ILD的灵敏度93.8%、特异度86.9%。
  • LUS评分与所有QCT参数正相关,尤其与纤维化范围(r=0.784;p<0.001)。

关键数值与推荐

  • LUS评分 cutoff 5.5:区分非ILD与临床前ILD,灵敏度93.1%、特异度83.9%。
  • LUS评分 cutoff 14.5:区分非ILD与ILD,灵敏度93.8%、特异度86.9%。
  • LUS评分与QCT纤维化范围相关系数 r=0.784(p<0.001)。

临床怎么用

  • 对CTD且临床怀疑ILD的患者,可考虑采用14肋间扫描方案的LUS评分辅助早期识别ILD。
  • LUS评分可与QCT参数结合,评估ILD范围及纤维化程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The role of lung ultrasound's (LUS) in diagnosing and assessing connective tissue disease (CTD)-related interstitial lung disease (ILD) remains controversial. We aimed to evaluate the diagnostic performance of a quantitative LUS score and the correlations between LUS scores and quantitative computed tomography (QCT) parameters in patients with CTD-ILD. METHODS: This prospective study included individuals with CTD and clinical suspicion of ILD attending our hospital between December 2023 and November 2024. LUS was performed using a 14 intercostal scanning protocol; high-resolution computed tomography (HRCT) was analysed using artificial intelligence-based QCT software. Participants underwent pulmonary function tests (PFTs) and completed the King's Brief Interstitial Lung Disease (KBILD) questionnaire. We analysed the LUS score's diagnostic efficacy and its correlations with QCT findings, PFT results, and KBILD scores. RESULTS: Among 206 patients with CTD enrolled, 145, 30, and 31 were categorised into ILD, preclinical ILD, and non-ILD groups, respectively. Patients with ILD exhibited higher LUS scores and QCT parameters but lower PFT results and KBILD scores than those without ILD or with preclinical ILD. At cutoff scores of 5.5 and 14.5, LUS distinguished non-ILD from preclinical ILD and ILD with sensitivities of 93.1% and 93.8% (specificities: 83.9% and 86.9%, respectively). LUS scores correlated positively with all QCT parameters, particularly fibrosis extent (r = 0.784; p < 0.001). Median LUS scores differed significantly among PFT and HRCT-defined ILD extent groups. CONCLUSION: LUS facilitates early diagnosis of CTD-ILD, and quantitative LUS score correlates with QCT-defined ILD extent. TRIAL REGISTRATION: Chinese Clinical Trial Registry (registration number ChiCTR2400080909).

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Pang L, Guo N, et al. A Lung Ultrasound Score for Assessing Connective Tissue Disease-Related Interstitial Lung Disease: Performance and Comparison With Computed Tomography Quantification. Respirology. 2025. PMID: 41371908. doi:10.1002/resp.70182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。